Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Cellics Therapeutics, Inc. See All Filings	D	2022-02-17 15:28:57 UTC
Amount To Be Raised $25,000,000 Associated Brokers / Dealers N/A CIK Number 0001611752 Filed Document 0001611752-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-02-17 15:28:57 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Cellics Therapeutics, Inc. See All Filings	D	2020-06-08 20:09:25 UTC
Amount To Be Raised $13,000,635 Associated Brokers / Dealers N/A CIK Number 0001611752 Filed Document 0001611752-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-06-08 20:09:25 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Cellics Therapeutics, Inc. See All Filings	D	2018-04-23 13:28:04 UTC
Amount To Be Raised $6,999,983 Associated Brokers / Dealers N/A CIK Number 0001611752 Filed Document 0001611752-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-04-23 13:28:04 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Cellics Therapeutics, Inc. See All Filings	D/A	2017-04-21 16:31:48 UTC
Amount To Be Raised $6,000,050 Associated Brokers / Dealers N/A CIK Number 0001611752 Filed Document 0001611752-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-04-21 16:31:48 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Cellics Therapeutics, Inc. See All Filings	D	2016-02-04 00:00:00 UTC
Amount To Be Raised $6,000,050 Associated Brokers / Dealers N/A CIK Number 0001611752 Filed Document 0001611752-16-000002 Exclusions or Exemptions 506b Accepted Date 2016-02-04 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity